3351 Results

People

  1. Kris
    Kris
  2. Drilon
    Drilon
  3. Riely
    Riely
  4. Rudin
    Rudin
  5. Ladanyi
    Ladanyi
  6. Hellmann
    Hellmann
  7. Yu
    Yu
  8. Paik
    Paik
  9. Rusch
    Rusch
  10. Rekhtman
    Rekhtman

Groups

  1. Department of Medicine (3351)
  2. Solid Tumor Oncology Division (3351)
  3. Thoracic Oncology (3351)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Human Oncology and Pathogenesis Program (625)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (593)
  8. Weinberg Fellows (537)
  9. Sloan Kettering Institute Postdocs (491)
  10. Tow Center for Developmental Oncology (TCDO) (471)
  1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (1694)
  2. Journal Article (1416)
  3. Review (80)
  4. Editorial (56)
  5. Book Section (35)
  6. Guidelines (24)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3351)
  2. Solid Tumor Oncology Division (3351)
  3. Thoracic Oncology (3351)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Human Oncology and Pathogenesis Program (625)

More Groups

People
  1. Mark Kris (869)
  2. Alexander Drilon (631)
  3. Gregory Riely (599)
  4. Charles Rudin (488)
  5. Marc Ladanyi (414)
  6. Matthew Hellmann (411)

More People

Years
  1. 2025 (73)
  2. 2024 (270)
  3. 2023 (272)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (692)
  2. Journal of Thoracic Oncology (513)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (156)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (769)
  2. Elsevier Inc. (734)
  3. American Association for Cancer Research (383)
  4. Oxford University Press (350)
  5. Nature Publishing Group (148)
  6. Elsevier Science, Inc. (78)

More Publishers

Results (3351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Importance of distinguishing adenocarcinoma and squamous cell carcinoma in assessment of pathologic response after neoadjuvant chemotherapy
    Meeting Abstract

    Emoto, K.; Qu, Y.; Zheng, H.; Aly, R.; Eguchi, T.; Chaft, J.; Tan, K. S.; Kris, M.; Adusumilli, P.; Travis, W.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Genomic profiling of prostate cancer with EGFR family gene alterations-potential of clinical and therapeutic implications
    Meeting Abstract

    Momeni Boroujeni, A.; Gupta, S.; Li, B.; Al-Ahmadie, H.; Solit, D.; Reuter, V.; Gopalan, A.; Arcila, M.; Fine, S.; Ladanyi, M.; more...
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Activity of larotrectinib, a highly selective inhibitor of tropomyosin receptor kinase, in TRK fusion breast cancers
    Meeting Abstract

    Meric-Bernstam, F.; Shukla, N.; Peled, N.; Landman, Y.; Onitilo, A.; Montez, S.; Ku, N. C.; Hyman, D. M.; Drilon, A.; Hong, D. S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase II trial of tepotinib in patients with non-small cell lung cancer (NSCLC) harboring MET alterations: The VISION study
    Meeting Abstract

    Paik, P.; Cortot, A.; Felip, E.; Sakai, H.; Mazieres, J.; Horn, L.; Griesinger, F.; Bruns, R.; Scheele, J.; Straub, J.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of [fam-] trastuzumab deruxtecan (DS-8201a) in HER2-overexpressing or -mutated advanced non-small cell lung cancer
    Meeting Abstract

    Planchard, D.; Li, B. T.; Murakami, H.; Shiga, R.; Lee, C. C.; Wang, K.; Jänne, P. A.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Crizotinib in advanced ROS1-rearranged non-small cell lung cancer (NSCLC): Overall survival (OS) and updated safety from PROFILE 1001
    Meeting Abstract

    Shaw, A.; Riely, G. J.; Bang, Y. J.; Kim, D. W.; Camidge, D. R.; Shapiro, G. I.; Usari, T.; Wang, S. C.; Wilner, K.; Clark, J. W.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Activity of larotrectinib in TRK fusion lung cancer
    Meeting Abstract

    Drilon, A.; Kummar, S.; Moreno, V.; Patel, J.; Lassen, U.; Rosen, L.; Childs, B. H.; Nanda, S.; Cox, M. C.; Ku, N. C.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2
    Meeting Abstract

    Barlesi, F.; Drilon, A.; De Braud, F.; Cho, B. C.; Ahn, M. J.; Siena, S.; Krebs, M. G.; Lin, C. C.; John, T.; Tan, D. S. W.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden
    Journal Article

    Benayed, R.; Offin, M.; Mullaney, K.; Sukhadia, P.; Rios, K.; Desmeules, P.; Ptashkin, R.; Won, H.; Chang, J.; Halpenny, D.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Adrenal metastasectomy in the presence and absence of extraadrenal metastatic disease
    Journal Article

    Russo, A. E.; Untch, B. R.; Kris, M. G.; Chou, J. F.; Capanu, M.; Coit, D. G.; Chaft, J. E.; D'Angelica, M. I.; Brennan, M. F.; Strong, V. E.
    Annals of Surgery (2019)

    Fulltext@MSK | Save